14-104801808-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001137601.3(ZBTB42):c.611C>A(p.Pro204Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000286 in 1,397,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001137601.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB42 | NM_001137601.3 | c.611C>A | p.Pro204Gln | missense_variant | 1/1 | ENST00000342537.8 | NP_001131073.1 | |
ZBTB42 | NM_001370342.1 | c.611C>A | p.Pro204Gln | missense_variant | 2/2 | NP_001357271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB42 | ENST00000342537.8 | c.611C>A | p.Pro204Gln | missense_variant | 1/1 | 6 | NM_001137601.3 | ENSP00000409107.2 | ||
ZBTB42 | ENST00000555360.1 | c.611C>A | p.Pro204Gln | missense_variant | 2/2 | 1 | ENSP00000450673.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1397676Hom.: 0 Cov.: 84 AF XY: 0.00000435 AC XY: 3AN XY: 689308
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2024 | The c.611C>A (p.P204Q) alteration is located in exon 2 (coding exon 1) of the ZBTB42 gene. This alteration results from a C to A substitution at nucleotide position 611, causing the proline (P) at amino acid position 204 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at